Application no. and date | 20215879.6 (espacenet) (Federated) (European Patent Register), 20161101 | Patent/reg. no. and date | DK/EP 3827845, 20220330 | Publication date | 20210602 | Priority no. and date | US 201562250016 P, 20151103 | EP pub. no. and date |
EP 3827845 20210602 | Effective date | | Applicant/owner | Janssen Biotech, Inc., 800/850 Ridgeview Drive
Horsham, PA 19044, US | Applicant ref. no. | P79438DK01 | Inventor | JANSSON, Richard, 3041 Ursulas Way
Doylestown, Pennsylvania 18902, US, KUMAR, Vineet, 1400 McKean Road
Spring House, Pennsylvania 19477, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/198 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/573 (2006.01) , A61K 31/69 (2006.01) , A61K 39/395 (2006.01) , A61K 47/12 (2006.01) , A61K 47/20 (2006.01) , A61K 47/22 (2006.01) , A61K 9/10 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | SUBKUTANE FORMULERINGER AF ANTI-CD38-ANTISTOFFER OG ANVENDELSER DERAF | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|